Is malignancy effective in the healing time of pressure ulcers in intensive care patients?

Basit Öğe Kaydı
dc.authoridKaraismailoglu, Eda/0000-0003-3085-7809
dc.contributor.authorArgun, Guldeniz
dc.contributor.authorAydin, Murat
dc.contributor.authorIncel, Gulyasar Ketenci
dc.contributor.authorKaraismailoglu, Eda
dc.date.accessioned2024-11-07T13:32:28Z
dc.date.available2024-11-07T13:32:28Z
dc.date.issued2021
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractAim: In this study, we aimed to investigate the duration of wound healing and an effective treatment management approach to patients with or without malignancy receiving wound care to provide effective wound care and to accelerate discharge. Material and Methods: Three hundred and forty-five patients who were treated in our clinic were included in the study. Records of patients with pressure ulcers among those who stayed in the Surgical Intensive Care Unit between January 1, 2018 and January 1, 2020 were accessed. Patients' pressure ulcers were graded on the Waterlow scale and standardized therapies were applied according to the grades. Dates of admission to the Intensive Care Unit (ICU), the pressure ulcers grades, comorbidities, laboratory values, administered treatment protocols and treatment response times were retrieved from the records and evaluated. Results: The patients were divided into two groups: patients with malignancy (Group M, n = 78) and those without malignancy (Group NM, n = 73). Comparison of all parameters according to pressure ulcer stages revealed a significantly low albumin level in malignant patients with Stage 2 and 3 pressure ulcers when compared to the non-malignant patients (Group M / Group NM, Stage 2 p<.01 and stage 3 p = 0.015). In malignant patients with low albumin levels and Stage 2 pressure ulcers, the wound healing time was prolonged statistically significant (Group M/Group NM, 13.28 +/- 5.64/11.50 +/- 6.34 days, p = 0.047). No significant difference was established in the mean duration of wound healing between patients with and without malignancy when groups were taken up in general (Group M/Group NM: 8.00 +/- 6.49 / 6.67 +/- 6.35 days, p = 0.52). Discussion: Malignancy does not play a role in the duration of wound healing in malignant and non-malignant patients treated in the intensive care unit at stage 1 pressure wounds. Furthermore, there is a difference in the duration of wound healing between malignant and non-malignant patients, even for Stage 2 and 3 pressure ulcers on the Waterlow scale.
dc.identifier.doi10.4328/ACAM.20763
dc.identifier.endpage1392
dc.identifier.issn2667-663X
dc.identifier.issue12
dc.identifier.startpage1388
dc.identifier.urihttps://doi.org/10.4328/ACAM.20763
dc.identifier.urihttps://hdl.handle.net/11480/15440
dc.identifier.volume12
dc.identifier.wosWOS:000732435100014
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBayrakol Medical Publisher
dc.relation.ispartofAnnals of Clinical and Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectCritical Care
dc.subjectPressure Ulcer
dc.subjectNeoplasms
dc.subjectWounds and Injuries
dc.titleIs malignancy effective in the healing time of pressure ulcers in intensive care patients?
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu